{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:41:16Z","timestamp":1791942076209,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T00:00:00Z","timestamp":1458086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s12022-016-9426-7","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T17:05:43Z","timestamp":1458320743000},"page":"87-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Role of Histological Criteria and Immunohistochemical Markers in Predicting Risk of Malignancy in Parathyroid Neoplasms"],"prefix":"10.1007","volume":"27","author":[{"given":"Niraj","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandita","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Krishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,16]]},"reference":[{"key":"9426_CR1","doi-asserted-by":"crossref","unstructured":"Pradeep PV, Jayashree B, Mishra A, Mishra SK. Systemic review of primary hyperparathyroidism in India: The past, present and the future trends. Int J Endocrinol. 2011. Available at doi: 10.1155\/2011\/921814 , Last accessed on 23rd August, 2015.","DOI":"10.1155\/2011\/921814"},{"key":"9426_CR2","first-page":"493","volume-title":"Sternberg\u2019s Diagnostic Surgical Pathology","author":"ZW Baloch","year":"2010","unstructured":"Baloch ZW, Livolsi VA. Pathology of thyroid and parathyroid disease. In: Mills SE, Carter D, Greenson JK, Reuter VE, Stoler MH. Sternberg\u2019s Diagnostic Surgical Pathology, 5th Edition, Lippincott Williams & Wilkins, Philadelphia, 2010:493\u2013544.","edition":"5"},{"key":"9426_CR3","unstructured":"Chan JKC. Tumors of thyroid and parathyroid glands. In: Fletcher CDM. Diagnostic Histopathology of Tumors. 4th Edition, Volume 2, Elsevier Saunders, China, 2013:pp1273-1293."},{"key":"9426_CR4","first-page":"45","volume":"12","author":"JK Chan","year":"1995","unstructured":"Chan JK, Tsang WY. Endocrine malignancies that may mimic benign lesions. SeminDiagnPathol 1995;12:45\u201363.","journal-title":"SeminDiagnPathol"},{"key":"9426_CR5","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1038\/modpathol.2010.132","volume":"24","author":"RA DeLellis","year":"2011","unstructured":"DeLellis RA. Parathyroid tumors and related disorders. Mod Pathol. 2011;24:S78- S93.","journal-title":"Mod Pathol."},{"key":"9426_CR6","unstructured":"Bondeson L, Grimelius L, DeLellis RA, Lioyd R, Akerstrom G, Larsson C, et al. Parathyroid carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C. World Health Organization Classification of Tumors, Pathology & Genetics Tumors of Endocrine Organs. IARC Press Lyon 2004:pp124-127."},{"key":"9426_CR7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/BF00353773","volume":"18","author":"K Sandelin","year":"1994","unstructured":"Sandelin K, Tullgren O, Farnebo LO. Clinical course of metastatic parathyroid cancer. World J Surg 1994;18:594\u2013598.","journal-title":"World J Surg"},{"key":"9426_CR8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1517\/17530059.1.3.377","volume":"1","author":"DJ Marsh","year":"2007","unstructured":"Marsh DJ, Hahn MA, Howell VM, Gill AJ. Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes. Expert Opin Med Diagn 2007;1:377\u2013392.","journal-title":"Expert Opin Med Diagn"},{"key":"9426_CR9","unstructured":"Chan JKC. Tumors of thyroid and parathyroid glands. In: Fletcher CDM. In Diagnostic Histopathology of Tumors. 2nd Edition, Volume 2, Churchill Livingstone, London, 2007:pp959-1056."},{"key":"9426_CR10","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","volume":"10","author":"MH Tan","year":"2004","unstructured":"Tan MH, Morrison C, Wang P, Yang X, Haven CJ, Zhang C, et al. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma.Clin Cancer Res. 2004;10:6629\u20136637.","journal-title":"Clin Cancer Res."},{"key":"9426_CR11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.humpath.2005.06.020","volume":"36","author":"N Bergero","year":"2005","unstructured":"Bergero N, De Pompa R, Sacerdote C, Gasparri G, Volante M, Bussolati G, et al. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. Hum Pathol. 2005;36:908\u2013914.","journal-title":"Hum Pathol."},{"key":"9426_CR12","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","volume":"30","author":"AJ Gill","year":"2006","unstructured":"Gill AJ, Clarkson A, Gimm O, Keil J, Dralle H, Howell VM, et al. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J SurgPathol. 2006;30:1140\u20131149.","journal-title":"Am J SurgPathol."},{"key":"9426_CR13","first-page":"59","volume":"126","author":"E Saggiorato","year":"2006","unstructured":"Saggiorato E, Bergero N, Volante M, Bacillo E, Rosas R, Gasparri G, et al. Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions. Am J ClinPathol. 2006;126:59\u201366.","journal-title":"Am J ClinPathol."},{"key":"9426_CR14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","volume":"156","author":"F Cetani","year":"2007","unstructured":"Cetani F, Ambrogini E, Viacava P, Pardi E, Fanelli G, Naccarato AG, et al. Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?Eur J Endocrinol. 2007;156:547\u2013554.","journal-title":"Eur J Endocrinol."},{"key":"9426_CR15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/ERC-07-0021","volume":"14","author":"CC Juhlin","year":"2007","unstructured":"Juhlin CC, Villablanca A, Sandelin K, Haglund F, Nordenstr\u00f6m J, Forsberg L, et al. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. EndocrRelat Cancer. 2007;14:501\u2013512.","journal-title":"EndocrRelat Cancer."},{"key":"9426_CR16","first-page":"481","volume":"34","author":"CC Juhlin","year":"2009","unstructured":"Juhlin CC, Haglund F, Villablanca A, Forsberg L, Sandelin K, Br\u00e4nstr\u00f6m R, et al. Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.Int J Oncol. 2009;34:481\u2013492.","journal-title":"Int J Oncol."},{"key":"9426_CR17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","volume":"115","author":"G Gustavo","year":"2009","unstructured":"Gustavo G, Fernandez-Ranvier GG, Khanafshar E, Tacha D, Wong M, Kebebew E, et al. Defining a Molecular Phenotype for Benign and Malignant Parathyroid tumors. Cancer. 2009;115:334\u2013344.","journal-title":"Cancer."},{"key":"9426_CR18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12022-010-9121-z","volume":"21","author":"CC Juhlin","year":"2010","unstructured":"Juhlin CC, Nillson IL, Johansson K, Haqlund F, Villablanca A, Hooq A, et al. Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas. Endocr Pathol 2010;21:166\u2013177.","journal-title":"Endocr Pathol"},{"key":"9426_CR19","first-page":"2895","volume":"125","author":"O Wang","year":"2012","unstructured":"Wang O, Wang CY, Shi J, Nie M, Xia WB, Li M, et al. Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors. Chinese Medical Journal 2012;125:2895\u20132901.","journal-title":"Chinese Medical Journal"},{"key":"9426_CR20","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00268-014-2700-2","volume":"38","author":"PP Truran","year":"2014","unstructured":"Truran PP, Johnson SJ, Bliss RD, Lennard TWJ, Aspinall SR. Parafibromin, Galectin-3, PGP9.5, Ki67, and Cyclin D1: Using an Immunohistochemical Panel to Aid in the Diagnosis of Parathyroid Cancer. World J Surg 2014;38:2845\u20132854.","journal-title":"World J Surg"},{"key":"9426_CR21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hed.21716","volume":"34","author":"HK Kim","year":"2012","unstructured":"Kim HK, Oh YL, Kim SH, Lee DY, Kang HC, Lee JI, et al. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma. Head Neck 2012;34:201\u2013206.","journal-title":"Head Neck"},{"key":"9426_CR22","doi-asserted-by":"crossref","unstructured":"Howell VM, Gill A, Clarkson A, Nelson AE, Dunne R, Delbridge LW, et al. Accuracy of combined gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab. 2009;94:434\u2013441.","DOI":"10.1210\/jc.2008-1740"},{"key":"9426_CR23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","volume":"21","author":"S Kruijff","year":"2014","unstructured":"Schelto Kruijff, Stan B. Sidhu, Mark S. Sywak, Anthony J. Gill, Leigh W. Delbridge. Negative Parafibromin Staining Predicts Malignant Behavior in Atypical Parathyroid Adenomas. Ann Surg Oncol. 2014;21:426\u2013433.","journal-title":"Ann Surg Oncol."}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-016-9426-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-016-9426-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-016-9426-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:01:09Z","timestamp":1559426469000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-016-9426-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,16]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["9426"],"URL":"https:\/\/doi.org\/10.1007\/s12022-016-9426-7","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,16]]}}}